Qualigen Therapeutics Inc (NASDAQ:QLGN) has a beta value of -0.16 and has seen 40.81 million shares traded in the recent trading session. The company, currently valued at $7.75M, closed the recent trade at $4.74 per share which meant it gained $1.21 on the day or 34.28% during that session. The QLGN stock price is -300.84% off its 52-week high price of $19.00 and 39.87% above the 52-week low of $2.85. If we look at the company’s 10-day average daily trading volume, we find that it stood at 26190.0 shares traded. The 3-month trading volume is 24.14K shares.
Qualigen Therapeutics Inc (NASDAQ:QLGN) trade information
Sporting 34.28% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the QLGN stock price touched $4.74 or saw a rise of 28.94%. Year-to-date, Qualigen Therapeutics Inc shares have moved -78.16%, while the 5-day performance has seen it change 34.70%. Over the past 30 days, the shares of Qualigen Therapeutics Inc (NASDAQ:QLGN) have changed 27.69%. Short interest in the company has seen 27806.0 shares shorted with days to cover at 3.08.
Qualigen Therapeutics Inc (QLGN) estimates and forecasts
The company’s shares have gained 15.61% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 79.32% over the past 5 years.
QLGN Dividends
Qualigen Therapeutics Inc is expected to release its next earnings report on 2024-Apr-08 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Qualigen Therapeutics Inc (NASDAQ:QLGN)’s Major holders
Insiders own 3.77% of the company shares, while shares held by institutions stand at 1.17% with a share float percentage of 1.22%. Investors are also buoyed by the number of investors in a company, with Qualigen Therapeutics Inc having a total of 10.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . As of May 31, 2025 , the former fund manager holds about 0.24% shares in the company for having 3.9 shares of worth $17735.0 while later fund manager owns 1.96 shares of worth $8899.0 as of May 31, 2025 , which makes it owner of about 0.12% of company’s outstanding stock.
